The Independent Cosmetic Manufacturers and Distributors is confident for now that cosmetics reform legislation will not advance in the Senate without broad industry backing, but visibility beyond 2020 is limited, the organization says.
Leading off ICMAD’s FDA Regulatory Workshop May 9 in New York, Corporate Secretary and General Counsel Sharon Blinkoff restated the group’s position that cosmetics bills under consideration in the 116th Congress – similar to predecessors in previous sessions – exceed what is